Skip to main content
Erschienen in: Lung 3/2007

01.05.2007 | ORIGINAL PAPER

Association of HLA Class II Genes with Idiopathic Pulmonary Arterial Hypertension in Koreans

verfasst von: Sung-Ho Yoon, Heung-Bum Oh, Hyun-Kuk Kim, Suk-Chan Hong, Yeon-Mok Oh, Dong Soon Lee, Sang-Do Lee

Erschienen in: Lung | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to compare the frequency of the HLA-DRB1 and HLA-DQB1 alleles in Korean patients with idiopathic pulmonary arterial hypertension (IPAH) and in normal controls and to determine any association that may exist between clinical characteristics of IPAH and specific HLA alleles. IPAH patients seen between October 1998 and September 2001 were retrospectively assessed, and 19 patients and 193 controls were HLA typed at the HLA-DRB1 and DQB1 loci. Clinical characteristics and hemodynamic parameters were reviewed. The patients with IPAH had a significantly higher frequency of the HLA-DRB1*0406 allele (18% vs. 6%, p = 0.004) and the HLA-DQB1*0302 allele (24% vs. 12%, p = 0.034), as well as a significantly higher frequency of haplotype DRB1*0406-DQB1*0302 (p = 0.0006). All 6 patients with haplotype DRB1*0406-DQB1*0302 (H+ group) were women, compared with 8 of the 13 patients lacking the DRB1*0406-DQB1*0302 haplotype (H- group), but without statistical significance. Three of 19 patients showed a positive short-term hemodynamic response to NO inhalation, all 3 of whom had the DRB1*0406-DQB1*0302 haplotype. There were no other significant differences in clinical characteristics and hemodynamic parameters between the H+ and H- groups. We conclude from this study that the HLA-DRB1*0406-DQB1*0302 haplotype is associated with IPAH in Korean patients. These results suggest that certain clinical characteristics of IPAH may be controlled in part by patients’ HLA alleles.
Literatur
1.
Zurück zum Zitat Barst RJ, Loyd JE (1998) Genetics and immunogenetic aspects of primary pulmonary hypertension. Chest 114(3 Suppl):231S–236SPubMed Barst RJ, Loyd JE (1998) Genetics and immunogenetic aspects of primary pulmonary hypertension. Chest 114(3 Suppl):231S–236SPubMed
3.
Zurück zum Zitat Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SL, Levy PC, Reid LM, Vreim CE, Williams GW (1987) Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107:216–223PubMed Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SL, Levy PC, Reid LM, Vreim CE, Williams GW (1987) Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107:216–223PubMed
4.
Zurück zum Zitat Rich S, Kieras K, Hart K, Groves BM, Stodo JD, Brundage BH (1986) Antinuclear antibodies in primary pulmonary hypertension. J Am Coll Cardiol 8:1307–1311PubMedCrossRef Rich S, Kieras K, Hart K, Groves BM, Stodo JD, Brundage BH (1986) Antinuclear antibodies in primary pulmonary hypertension. J Am Coll Cardiol 8:1307–1311PubMedCrossRef
5.
Zurück zum Zitat Isern RA, Yaneva M, Weiner E, Parke A, Rothfield N, Dantzker D, Rich S, Arnett FC (1992) Autoantibodies in patients with primary pulmonary hypertension; association with anti-Ku. Am J Med 93:307–312PubMedCrossRef Isern RA, Yaneva M, Weiner E, Parke A, Rothfield N, Dantzker D, Rich S, Arnett FC (1992) Autoantibodies in patients with primary pulmonary hypertension; association with anti-Ku. Am J Med 93:307–312PubMedCrossRef
6.
Zurück zum Zitat Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD (1990) Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med 322:1836–1841PubMedCrossRef Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD (1990) Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med 322:1836–1841PubMedCrossRef
7.
Zurück zum Zitat Barst RJ, Flaster ER, Menon A, Fotino M, Morse JH (1992) Evidence for the association of unexplained pulmonary hypertension in children with the major histocompatibility complex. Circulation 85:249–258PubMed Barst RJ, Flaster ER, Menon A, Fotino M, Morse JH (1992) Evidence for the association of unexplained pulmonary hypertension in children with the major histocompatibility complex. Circulation 85:249–258PubMed
8.
Zurück zum Zitat Langevitz P, Buskila D, Gladman DD, Darlington GA, Farewell VT, Lee P (1992) HLA alleles in systemic sclerosis: association with pulmonary hypertension and outcome. Br J Rheumatol 31:609–613PubMedCrossRef Langevitz P, Buskila D, Gladman DD, Darlington GA, Farewell VT, Lee P (1992) HLA alleles in systemic sclerosis: association with pulmonary hypertension and outcome. Br J Rheumatol 31:609–613PubMedCrossRef
9.
Zurück zum Zitat Tanabe N, Kimura A, Amano S, Okada O, Kasahara Y, Tatsumi K, Takahashi M, Shibata H, Yasunami M, Kuriyama T (2005) Association of clinical features with HLA in chronic pulmonary thromboembolism. Eur Respir J 25:131–138PubMedCrossRef Tanabe N, Kimura A, Amano S, Okada O, Kasahara Y, Tatsumi K, Takahashi M, Shibata H, Yasunami M, Kuriyama T (2005) Association of clinical features with HLA in chronic pulmonary thromboembolism. Eur Respir J 25:131–138PubMedCrossRef
10.
Zurück zum Zitat Powe JE, Palevsky HI, McCarthy KE, Alavi A (1987) Pulmonary arterial hypertension: value of perfusion scintigraphy. Radiology 164:727–730PubMed Powe JE, Palevsky HI, McCarthy KE, Alavi A (1987) Pulmonary arterial hypertension: value of perfusion scintigraphy. Radiology 164:727–730PubMed
11.
Zurück zum Zitat Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, Berman LB (1985) The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 132:919–923PubMed Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, Berman LB (1985) The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 132:919–923PubMed
12.
Zurück zum Zitat Hoeper MM, Maier R, Tongers J, Neidermeyer J, Hohlfeld JM, Hamm M, Fabel H (1999) Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension. Am J Respir Crit Care Med 160:535–541PubMed Hoeper MM, Maier R, Tongers J, Neidermeyer J, Hohlfeld JM, Hamm M, Fabel H (1999) Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension. Am J Respir Crit Care Med 160:535–541PubMed
13.
Zurück zum Zitat Badesch DB, Abman SH, Ahearn GS, Barst RJ, McCrory DC, Simonneau G, McLaughlin VV (2004) Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126(1 Suppl):35S–62SPubMedCrossRef Badesch DB, Abman SH, Ahearn GS, Barst RJ, McCrory DC, Simonneau G, McLaughlin VV (2004) Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126(1 Suppl):35S–62SPubMedCrossRef
14.
Zurück zum Zitat Park MH, Hwang YS, Park KS, Tokunaga K, Akaza T, Juji T, Kim SI (1998) HLA haplotypes in Koreans based on 107 families. Tissue Antigens 51:347–355PubMedCrossRef Park MH, Hwang YS, Park KS, Tokunaga K, Akaza T, Juji T, Kim SI (1998) HLA haplotypes in Koreans based on 107 families. Tissue Antigens 51:347–355PubMedCrossRef
15.
Zurück zum Zitat Lane KB, Machado RD, Pauciulo MW, Thomson JR, Philips JA 3rd, Loyd JE, Nichols WC, Trembath RC (2000) Heterozygous germ-line mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet 26:81–84PubMedCrossRef Lane KB, Machado RD, Pauciulo MW, Thomson JR, Philips JA 3rd, Loyd JE, Nichols WC, Trembath RC (2000) Heterozygous germ-line mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet 26:81–84PubMedCrossRef
16.
Zurück zum Zitat Machado RD, Pauciulo MW, Thomson JR, Lane KB, Morgan NV, Wheeler L, Phillips JA 3rd, Newman J, Williams D, Galiè N, Manes A, McNeil K, Yacoub M, Mikhail G, Rogers P, Corris P, Humbert M, Donnai D, Martensson G, Tranebjaerg L, Loyd JE, Trembath RC, Nichols WC (2001) BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet 68:92–102PubMedCrossRef Machado RD, Pauciulo MW, Thomson JR, Lane KB, Morgan NV, Wheeler L, Phillips JA 3rd, Newman J, Williams D, Galiè N, Manes A, McNeil K, Yacoub M, Mikhail G, Rogers P, Corris P, Humbert M, Donnai D, Martensson G, Tranebjaerg L, Loyd JE, Trembath RC, Nichols WC (2001) BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet 68:92–102PubMedCrossRef
17.
Zurück zum Zitat Newman JH, Wheeler L, Lane KB, Loyd E, Gaddipati R, Phillips JA 3rd, Loyd JE (2001) Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. N Engl J Med 345:319–324PubMedCrossRef Newman JH, Wheeler L, Lane KB, Loyd E, Gaddipati R, Phillips JA 3rd, Loyd JE (2001) Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. N Engl J Med 345:319–324PubMedCrossRef
18.
Zurück zum Zitat Fuster V, Steele PM, Edwards WD, Gersh BJ, McGoon MD, Frye RL (1984) Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 70:580–587PubMed Fuster V, Steele PM, Edwards WD, Gersh BJ, McGoon MD, Frye RL (1984) Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 70:580–587PubMed
19.
Zurück zum Zitat Archer S, Rich S (2000) Primary pulmonary hypertension; A vascular biology and translational research “Work in Progress”. Circulation 102: 2781–2791PubMed Archer S, Rich S (2000) Primary pulmonary hypertension; A vascular biology and translational research “Work in Progress”. Circulation 102: 2781–2791PubMed
Metadaten
Titel
Association of HLA Class II Genes with Idiopathic Pulmonary Arterial Hypertension in Koreans
verfasst von
Sung-Ho Yoon
Heung-Bum Oh
Hyun-Kuk Kim
Suk-Chan Hong
Yeon-Mok Oh
Dong Soon Lee
Sang-Do Lee
Publikationsdatum
01.05.2007
Verlag
Springer-Verlag
Erschienen in
Lung / Ausgabe 3/2007
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-007-9006-1

Weitere Artikel der Ausgabe 3/2007

Lung 3/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.